RSV Vaccine Safety Signals Raise Alarming Questions
A new peer-reviewed pharmacovigilance study published in Human Vaccines & Immunotherapeutics analyzed nearly 18,000 adverse event reports tied to the three FDA-approved RSV vaccines — Pfizer’s Abrysvo, GSK’s Arexvy, and Moderna’s mRESVIA. The results raise urgent concerns about vaccine safety, especially for seniors and pregnant women. A Pharmacovigilance Study with Stark Findings Researchers used standard […]
Discuss on Nostr!
Nostr Note ID note1z9f7tlrzf9mluf0mes72pgxuyztllrsnunxqzgtp3f5hdtrdee3sefkmsn Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.